... / ... / ... / Research Projects / FLUNIVAC

FLUNIVAC

Logo_FlunivacFLUNIVAC is a SME-targeted collaborative research project that aims to develop a candidate influenza vaccine based on recombinant MVA expressing both antibody and T-cell response-inducing proteins, ready to commence Phase I clinical trials within 4 years.

Read more: Website FLUNIVAC